Characteristics and Mortality Outcomes in Homebound HFpEF Patients

被引：0
|
作者：
Chiong, C. L. [1 ,2 ]
Chiong, C. [2 ]
Miller, A. B. [3 ]
机构：
[1] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[2] MedEx Hlth Network Inc, Redlands, CA USA
[3] Univ Florida Shands Jacksonville, Jacksonville, FL USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2021年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
D187
引用
收藏
页码：S288 / S289
页数：2
相关论文
共 50 条
  • [31] Outcomes With sGC Therapy in Patients With HFpEF: A Meta-Analysis of Prior Trials
    Thakker, Ravi A.
    Elbadawi, Ayman
    Albaeni, Aiham
    Perez, Christopher
    Hasan, Syed Mustajab
    Murrieta, Jose Iturrizaga
    Almustafa, Ahmed
    Duarte, Alexander
    Berbarie, Rafic F.
    Chatila, Khaled F.
    Khalife, Wissam
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (09)
  • [32] Dapagliflozin improves outcomes in HFmrEF and HFpEF
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2022, 19 : 719 - 719
  • [33] Finerenone improves outcomes in HFmrEF and HFpEF
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2024, 21 (11) : 739 - 739
  • [34] How to care for homebound patients?
    Low, Sher Guan
    Ng, Lawrence Chee Lian
    Tan, Josephine See Woon
    Vasanwala, Farhad Fakhrudin
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2016, 25 (03) : 181 - 184
  • [35] Endotrophin is Significantly Associated With Risk of Mortality in HFpEF Patients Irrespective of Underlying Atrial Fibrillation
    Reese-petersen, Alexander L.
    Gonzalez, Arantxa
    Lopez, Begona
    Ravassa, Susana
    Karsdal, Morten
    Genovese, Federica
    Diez, Javier
    CIRCULATION, 2021, 144
  • [36] Worsening Renal Function and Adverse Outcomes in Patients with HFpEF with or without Atrial Fibrillation
    Guo, Linjuan
    Wu, Xiaojuan
    BIOMEDICINES, 2023, 11 (09)
  • [37] Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
    Kristensen, Soren L.
    Jhund, Pardeep S.
    Lee, Matthew M. Y.
    Kober, Lars
    Solomon, Scott D.
    Granger, Christopher B.
    Yusuf, Salim
    Pfeffer, Marc A.
    Swedberg, Karl
    McMurray, John J. V.
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (5-6) : 545 - 549
  • [38] Ubiquity of Multimorbidity: Comorbid Conditions and Mortality in HFpEF
    Kamat, Ishan
    Nair, Ajith
    CIRCULATION-HEART FAILURE, 2025, 18 (03)
  • [39] Beta Blockers Are Associated With Reduced All-cause Mortality Among HFpEF Patients
    Ibrahim, Joseph
    Fabrizio, Carly
    Sezer, Ahmet
    Thoma, Floyd
    Boyle, Brendan
    Simon, Marc
    Mulukutla, Suresh
    Hickey, Gavin
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 656 - 656
  • [40] Beta blockers are associated with lower all-cause mortality among HFpEF patients
    Ibrahim, Joseph
    Fabrizio, Carly
    Sezer, Ahmet
    Thoma, Floyd
    Boyle, Brenden
    Mulukutla, Suresh R.
    Huston, Jessica H.
    Simon, Marc A.
    Hickey, Gavin W.
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, 113 (06) : 951 - 958
12345